Deep Breaths: Updates from CHEST

Guest: Ashwin Basavaraj, MD Host: Christopher Lippincott, MD, MPH From airway clearance techniques and mucoactive therapy—what can clinicians do to manage bronchiectasis exacerbations? To answer this question, Dr. Christopher Lippincott and Dr. Ashwin Basavaraj explore the mechanisms that lead to bronchiectasis and share strategies to manage exacerbations. This program is produced in partnership with the American College of CHEST Physicians, and is sponsored by Insmed Incorporated.

Host: Stephanie Christenson, MD Guest: Ron Balkissoon, MD, MSc, DIH, FRCPC What is a COPD exacerbation, and what puts our patients at risk of them? Drs. Stephanie Christenson and Ron Balkissoon discuss these risks and the burden of COPD exacerbations on our patients. This is a non-promotional, non-CME disease state educational program brought to you by CHEST in collaboration with and sponsored by GSK.

Host: Randy Young, MD Guest: Daniel Jay Feinstein, MD, FACP, MS, ACRP-PI Diagnosing pneumonia can be challenging, but the CAP guidelines offer recommendations to improve the detection of this infection. To find out more about the recommendations, Dr. Randy Young and Dr. Daniel Feinstein, a Physician Executive at Novant Health, dive into testing for pneumonia. This is a non-promotional, non-CME disease state educational podcast produced in partnership with the American College of Chest Physicians and is supported by bioMèrieux.

Host: Doreen Addrizzo-Harris, MD Guest: Ashwin Basavaraj, MD From evaluating diagnostic criteria to nonpharmacologic therapy, what do the NTM guidelines recommend when it comes to the treatment of MAC lung disease? Drs. Doreen Addrizzo-Harris and Ashwin Basavaraj from NYU Grossman School of Medicine will dive into the practical application of the NTM guidelines. This program is produced in partnership with the American College of CHEST Physicians, and is sponsored by Insmed Incorporated.

Host: David Schulman, MD, MPH, FCCP Guest: Andrew H. Limper, MD Guest: Timothy A. Hernandez, MD There are many barriers to reaching a definitive diagnosis for idiopathic pulmonary fibrosis (IPF). To learn more about these obstacles—and how we can overcome them—Dr. David Schulman from the American College of Chest Physicians joins Dr. Tim Hernandez from the University of Texas Health Sciences Center and Dr. Andrew Limper from the Mayo Clinic to discuss the diagnosis of IPF. This is a non-promotional, non-CME disease state educational podcast produced in partnership with the American College of Chest Physicians and is supported by Three Lakes Foundation. Click here to receive updates on Bridging Specialties™ and how you can be involved.

Host: Peter Howarth BSc, (Hons), MBBS, DM, FRCP Guest: Ian Pavord, MA, DM, FRCP, FERS, FMedSci Guest: Geoffrey Chupp, MD Type 2 inflammation can be challenging to identify. What should we be looking for in our patients with severe asthma and COPD? Joining Dr. Peter Howarth to discuss identifying this type of inflammation are Dr. Geoffrey Chupp from the Yale School of Medicine and Dr. Ian Pavord from the University of Oxford. This is a nonpromotional, non-CME disease state educational podcast brought to you by the American College of CHEST Physicians in collaboration with and paid for by GSK.

Host: Megan Conroy, MD, MA(Ed), FCCP Guest: Farrukh Abbas, MD On average, more than two-thirds of patients with chronic obstructive pulmonary disease (COPD) make at least one error in using an inhaler device. Fortunately, nebulized long-acting muscarinic antagonists (LAMAs) can help our patients overcome this common challenge in COPD care. That’s why Drs. Megan Conroy and Farrukh Abbas come together to talk about the GOLD treatment guidelines, strategies for reducing patient hesitancy regarding nebulized LAMAs, and more. This episode is produced in partnership with the American College of CHEST Physicians and is sponsored by Viatris Inc.

Guest: Jared Nathan Silver, MD, PhD Guest: Praveen Akuthota, MD Eosinophilic granulomatosis with polyangiitis and hypereosinophilic syndromes are often mistaken for each other. How can we better distinguish these diseases? Dr. Jared Silver discusses how to diagnose these diseases with Dr. Praveen Akuthota, a pulmonologist from U.C. San Diego Medical Center in California. This is a non-promotional, non-CME disease state disease education podcast series brought to you by American College of CHEST Physicians in collaboration with and paid for by GSK.